Parameters | The control group (n = 60) | The hemostasis group (n = 60) | P-value |
---|---|---|---|
Sex (n, %) | 0.256 | ||
Male | 41(68.3%) | 35(58.3%) | |
Female | 19(31.7%) | 25(41.7%) | |
Age (years,mean ± SD) | 45.6 ± 11.0 | 48.0 ± 11.9 | 0.261 |
Weight (kg,mean ± SD) | 66.2 ± 6.8 | 65.4 ± 6.0 | 0.461 |
BMI (kg/m2,mean ± SD) | 25.2 ± 3.0 | 25.7 ± 2.9 | 0.363 |
Side (n, %) | 0.461 | ||
Right | 28(46.7%) | 24(40.0%) | |
Left | 32(53.3%) | 36(60.0%) | |
Urine culture (n, %) | 0.591 | ||
Positive | 9(15.0%) | 7(11.7%) | |
Negative | 51(85.0%) | 53(88.3%) | |
Stone burden (mm2, mean ± SD) | 611.4 ± 282.4 | 562.8 ± 274.0 | 0.341 |
Calyx of puncture | 0.442 | ||
Upper calyx | 34(56.7%) | 27(45.0%) | |
Middle calyx | 22(36.7%) | 28(46.7%) | |
Lower calyx | 4(6.7%) | 5(8.3%) | |
Grade of hydronephrosis | 0.584 | ||
Mild to Moderate | 28(46.7%) | 31(51.7%) | |
Moderate to severe | 32(53.3%) | 29(48.3%) | |
Comorbidities | 0.764 | ||
Hypertension | 4(6.7%) | 4(6.7%) | |
Diabetes mellitus | 5(8.3%) | 3(5.0%) |